Form 990 for tax year 2024

Totals

Total revenue

$34,039,876

Total expenses

$30,603,995

Contributions and grants received

$1,166,781

Grants paid

$60,000

Program service revenue

$30,572,532

Investment income

$2,281,435

Other revenue

$19,128

Total assets, end of year

$48,487,446

Total liabilities, end of year

$22,914,001

Net assets or fund balances, end of year

$25,573,445

Program services expenses (Part IX)

$24,289,326

Management and general expenses

$5,672,481

Fundraising expenses

$642,188

Program service expenses (Part III)

$24,289,326

Program services were 79.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Mission and programs · 2024

• RESORING SIGHT Eversight continues to take meaningful steps toward transforming the future of vision care by supporting sustainable eye banking infrastructure and providing priceless clinical education. In 2024, Eversight provided the gift of sight to more than 10,200 people across the United States and around the world. Eversight provided 59 corneas for sight-restoring transplants gratis or at a reduced fee for uninsured patients.Eversight's work began in 1947 with the establishment of the fourth eye bank in the United States, then known as the Illinois Eye-Bank. Over time, nonprofit eye banks were established in every state to meet the critical demand for corneal tissue to treat preventable blindness.In 1985, the Illinois Eye-Bank and Michigan Eye-Bank formed a partnershipone that would earn a reputation for clinical excellence made possible by some of the finest medical directors, staff and board members in the eye banking field. The success of the organization attracted affiliations with other regional eye banks forming one of the largest networks of eye banks in the U.S. In 2015, the network became known as Eversight, all working together as a unified operation to deliver the highest quality services to surgeons and their patients and to continue to grow our impact around the world.Eversight provided more than 14,900 tissues for transplantation, research and education globally in 2024. We worked or placed tissue with physicians and researchers in 34 countries and facilitated training for 918 clinicians. Together with all our partnersadvocates, donor families, transplant recipients, surgeons, Lions, fellow eye banks, healthcare leaders, philanthropic supporters and many otherswe were able to make vision a reality for more people worldwide.

  Expenses $23,033,157 · Revenue $28,388,552

• FINDING A CURE In the pursuit of eliminating blinding eye diseases, Eversight established the Eversight Center for Vision and Eye Banking Research in Cleveland, Ohio, to provide leading ophthalmology researchers with the resources they need to find cures and treatments for eye diseases such as age-related macular degeneration, diabetic retinopathy and glaucoma. Eversight provided more than 4,700 tissues for research and education purposes in 2024. Our in-house research team also provided Eversight partners with valuable research and development services and pioneered new eye banking practices.Since 2014, the Eversight researchers have authored 50 publications and given 34+ presentations at international conferences. The team published six publications in 2024 on: comparing cornea storage medias, perceptions of cornea and eye donation, automated counting and density of donor endothelial cells, protocol for corneal stromal stem cell cultivation, using trypan blue for cell viability after preloading DMEK grafts, and docosahexaenoic acid in diabetic humans and mice. With our many academic partners, Eversight researchers have contributed to over 250 peer-reviewed scientific papers that have garnered 6,300 citations and counting.Eversight has a longstanding track record of research and development, having awarded more than $4 million in grants to date that stimulate pioneering clinical and basic science research aiming to develop new ways to restore sight, prevent blindness and ultimately help patients live life to the fullest. Since 1980, our Eye & Vision Research Grant Program has supported researchers at leading academic medical institutions including Harvard, Tufts, Cleveland Clinic, Case Western Reserve, University of Michigan, Northwestern and more. By design, Eversight's grant program provides critical, early-stage funding that is intended to drive foundational research and discovery. Many of these projects have stimulated larger-scale studies and won further financial support from the National Institutes of Health.In the 2025 funding cycle, Eversight awarded four grants at Loyola University Chicago, University of Houston, University of Illinois Chicago and University of Michigan to advance studies to investigate developing a novel drug evaluation system to stimulate blood vessel growth experimentally using factors that have been linked to the pathophysiology of both wAMD and PDR; enhancing limbal stem cell preservation; understanding the biomechanics of keratoconus by looking at the composition and microstructure of normal human and keratoconus corneal extracellular matrix; and advancing therapies for ocular surface squamous neoplasia. Each year, recipients are selected by an independent review panel of academic researchers and ophthalmologists. This distinguished panel awards proposals that encourage meaningful scientific inquisition and align with Eversight's mission to restore sight and prevent blindness through the healing power of donation, transplantation and research.

  Expenses $193,609 · Grants $60,000 · Revenue $75,664

• SUSTAINABLE INTERNATIONAL IMPACTEversight works to eliminate corneal blindness worldwide through eye bank development, clinical training and tissue provision. With more than 75 years of eye banking expertise, we deliver both short- and long-term solutions to transform the lives of more than 12 million people suffering from corneal blindness globally. In 2024, Eversight International provided more than 4,200 tissues for transplant and worked with surgeons in 33 countries outside the United States, making the gift of sight possible for many in need. Eversight provided 76 cornea tissues for sight-restoring transplants gratis or at a reduced rate for medical missions and uninsured patients outside the United States.In medically underserved areas, Eversight Global Development fosters authentic relationships with local leaders to establish culturally informed eye donation frameworks and sustainable eye banking infrastructure. Our experienced team offers vital clinical training and education to eye surgeons and eye bank technicians on the latest clinical methods, improving access to life-changing transplants. Through the incredible generosity of our donors and donor families, Eversight Global Development also provides corneal tissue from the United States for transplant and research globally, providing hope for the future and restoring sight to patients in need. Our global mission is informed by and aligns with the United Nations Sustainable Development Goals (SDGs), with particular attention given to: #3 Good Health and Well-being, #4 Quality Education, #8 Decent Work and Economic Growth, #10 Reduced Inequalities and #11 Sustainable Cities & Communities. According to the World Health Organization, every dollar spent on improving eye health in underdeveloped areas generates a four-fold return on investment. To address systemic unmet need, Eversight actively works with medical professionals, governments, vision health organizations and other NGOs in regions lacking eye banks and infrastructure, including United Arab Emirates, Pakistan and South Korea. With proven eye banking and technical training practicesand having played a part in the elimination of the U.S. cornea transplant waiting listEversight is uniquely qualified to work with countries lacking transplant programs to help them establish national networks for eye banking and cornea donation with culturally appropriate donation models and state-of-the-art clinical capabilities.Globally, an estimated 2.2 billion people are impacted by blindness and visual impairment. Ninety percent of vision-impaired people live in low- and middle- income countries. Approximately one billion of these individuals are coping with blindness or visual impairment that can be characterized as preventable or not sufficiently addressed. Vision loss results in substantial economic impact worldwide due to the inability of people who are vision impaired to contribute to their fullest in their communities. Eversight envisions a world without blindnessa world where all people in every community can lead independent, productive lives through the gift of sight. While providing for immediate global cornea transplant needs with U.S. donor tissue, Eversight continues to address the global burden by empowering international communities to take meaningful, sustainable steps every day to make vision a reality for all.

  Expenses $1,062,560 · Revenue $2,108,316

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

No itemized grants to organizations on this return.

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

• Eversight International

  501(c)(3) · Eye Bank · MI · controlled entity

  Directly controlled by Eversight

• Eversight New Jersey

  501(c)(3) · Eye Bank · NJ · controlled entity

  Directly controlled by Eversight

• Eversight Michigan

  501(c)(3) · Eye Bank · MI · controlled entity

  Directly controlled by Eversight

• Eversight Illinois

  501(c)(3) · Eye Bank · IL · controlled entity

  Directly controlled by Eversight

• Midwire Systems

  501(c)(3) · Software · MI · controlled entity

  Directly controlled by Eversight

• Eversight Ohio

  501(c)(3) · Eye Bank · OH · controlled entity

  Directly controlled by Eversight

• Eversight Connecticut

  501(c)(3) · Eye Bank · CT · controlled entity

  Directly controlled by Eversight

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Provenance

Return type

form_990

Tax year

2024

Filed

20 May 2025

IRS schema version

2024v5.2

Source object

202541989349301204

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.